US 9254274
Method of treating Tourette'S disorder with GABA-aminotransferase inactivators
granted A61KA61K31/13A61K31/131
Quick answer
US patent 9254274 (Method of treating Tourette'S disorder with GABA-aminotransferase inactivators) held by Catalyst Pharmaceuticals, Inc. expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Catalyst Pharmaceuticals, Inc.
- Grant date
- Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/13, A61K31/131, A61K31/195, A61K31/197